NN Investment Partners Holdings’s Charles River Laboratories CRL Stock Holding History

NN Investment Partners Holdings’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.11M	Buy	7,445 +1,867	+33%	+$576K	0.01%	537
2021 Q4	$2.1M	Buy	5,578 +1,774	+47%	+$689K	0.01%	539
2021 Q3	$1.57M	Buy	+3,804	New	+$1.58M	0.01%	580
2021 Q1	–	Sell	-900	Closed	-$225K	–	793
2020 Q4	$225K	Sell	900 -7,500	-89%	-$1.79M	﹤0.01%	709
2020 Q3	$1.9M	Buy	8,400 +6,300	+300%	+$1.31M	0.01%	495
2020 Q2	$366K	Hold	2,100	–	–	﹤0.01%	683
2020 Q1	$265K	Buy	+2,100	New	+$315K	﹤0.01%	672

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NN Investment Partners Holdings's CRL Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Charles River Laboratories (CRL) stake by 33% in Q1 2022, buying an estimated $576K and bringing the position to 7,445 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #537.

NN Investment Partners Holdings first reported a position in CRL in Q1 2020 and has held it in 7 quarters since. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

NN Investment Partners Holdings held 7,445 shares of Charles River Laboratories worth $2.11M as of Q1 2022.
NN Investment Partners Holdings bought 1,867 Charles River Laboratories shares in Q1 2022, an estimated $576K.
Charles River Laboratories made up 0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #537 holding.
NN Investment Partners Holdings first reported a position in Charles River Laboratories in Q1 2020 and has held it in 7 quarters since.
644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.